Ultra Solugauze .15 % Dressing is a Health Canada–registered human drug (DIN 00206857) held by Wallace, Cameron And Company Ltd., containing Domiphen Bromide. Health Canada lists its status as Cancelled Post Market (status date 20 Sep 1996). Nexara Health has matched 16 registrations of Domiphen Bromide across 2 other regulated markets.
Health Canada registration
| DIN | 00206857 |
|---|---|
| Brand name | Ultra Solugauze |
| Active ingredient | Domiphen Bromide |
| Strength | .15 % |
| Dosage form | Dressing |
| Route | Topical |
| Company | Wallace, Cameron And Company Ltd. |
| Status | Cancelled Post Market — 20 Sep 1996 |
| Class | Human |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Domiphen Bromide registered in other markets
16 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Bradoral Gargle Solution 1% (Domiphen Bromide) | 臺灣諾華股份有限公司新竹廠 | 漱口劑 | 已註銷 | TFDA | |
| Taiwan | Bradoral Spray 0.01% | Cimex S.a. | 口腔氣化噴霧劑 | 已註銷 | TFDA | |
| Taiwan | Bradral Lozenges 0.5mg (Domiphen) | 聯亞生技開發股份有限公司新竹廠 | 口含錠 | 已註銷 | TFDA | |
| Taiwan | Chief Lonzenges 0.5mg (Domiphen) "Meider" | 明德製藥股份有限公司 | 口含錠 | Registered | TFDA | |
| Taiwan | Docophen Tablets 0.5mg "Y.c."(Domiphen) | 元宙化學製藥股份有限公司 | 錠劑 | Registered | TFDA | |
| Taiwan | Drochen Lozenges 0.5mg | 應元化學製藥股份有限公司 | 錠劑 | Registered | TFDA | |
| Taiwan | Folison Lozenges 0.5mg"Y.k." (Domiphen) | 約克製藥股份有限公司 | 口含錠 | Registered | TFDA | |
| Taiwan | Fucole Horlen Lozenges | 永信藥品工業股份有限公司台中幼獅廠 | 口含錠 | Registered | TFDA | |
| United States | Domiphen Bromide | Chemische Fabrik Berg GmbH | Powder | FDA NDC | ||
| United States | Domiphen Bromide | PMC Isochem | Powder | FDA NDC |
See every manufacturer of Domiphen Bromide worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Ultra Solugauze (DIN 00206857) marketed in Canada?
No. Health Canada lists DIN 00206857 as Cancelled Post Market as of 20 Sep 1996.
Who holds the Canadian licence for this product?
Wallace, Cameron And Company Ltd. is the company of record in the Health Canada Drug Product Database.
Is Domiphen Bromide registered outside Canada?
Yes — Nexara Health has matched 16 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00206857, status date 1996-09-20; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00206857, status date 1996-09-20; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 00206857, status date 1996-09-20; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.